Real-World Evidence of the Effect of GLP-1 Receptor Agonist Treatment on the Adherence and Persistence of Second-Generation Antipsychotics Using Administrative Claims Data
Time: 10:00 am
day: Conference Day Two
Details:
- Discussing findings from administrative claims data analysis exploring the correlation between the initiation or continuation of GLP-1s and the subsequent adherence and persistence rates of second-generation antipsychotics in relevant patient populations
- Highlighting specific patient characteristic within claims data that demonstrate the effects of SGAs on GLP-1 adherence
- Exploring potential underlying mechanisms that might explain the observed real-world relationship and discussing the implications for clinical practice and treatment strategies for patients on both GLP-1s and SGA
